Ivimey

Ivimey is a patient who has benefited from comprehensive genomic profiling (CGP) and targeted therapy, having been diagnosed with cancer that harbored an EGFR gene mutation. After enrolling in a clinical trial for an EGFR inhibitor drug, she experienced a significant reduction in her tumor size, which allowed her to return to work and plan a family trip to Europe, showcasing the life-changing potential of personalized cancer treatments.